Micucci Matteo, Xiang Bian-Zhao, Ting Chen-Min, Kwan Hiu-Yee, Mari Michele, Retini Michele, Burattini Sabrina, Osman Riham, Okeke Udodinma Jude, Abdullah Fuad Othman, Gianfanti Federico, Battistelli Michela
Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino 61029, Italy.
Hong Kong Chinese Medicine Clinical Study Centre, Chinese EQUATOR Centre, School of Chinese Medicine, Chinese Clinical Trial Registry (Hong Kong), Hong Kong Baptist University, Hong Kong 999077, China.
World J Gastrointest Oncol. 2024 Sep 15;16(9):3798-3819. doi: 10.4251/wjgo.v16.i9.3798.
Gastric cancer (GC), the third leading cause of cancer-related death globally, is complex and heterogeneous. This review explores multidisciplinary investigations of traditional Chinese medicine (TCM) combined with Western medical practices, emphasizing the development of nutraceuticals for cancer prevention. Using advanced analytical chemistry and food chemistry techniques, this study investigated how TCM components may be optimized for nutraceutical development. Focusing on molecular interactions with GC pathways, particularly the NF-κB, PI3K/Akt, and Wnt/β-catenin pathways, we examined the effects of TCM polyherbal formulas, extracts, and isolated compounds. These agents modulate apoptosis and cellular proliferation, underscoring their potential in preventive strategies. The convergence of nutraceutical and medicine food homology studies highlights a significant shift towards integrating TCM-derived compounds in a preventive health framework. This approach aims not only to enhance efficacy and reduce side effects but also to champion a preventive paradigm using personalized medicine to advance proactive health maintenance and disease prevention. The combination of TCM and western medical practices offers promising avenues for future research and practical applications in GC prevention.
胃癌(GC)是全球癌症相关死亡的第三大主要原因,其具有复杂性和异质性。本综述探讨了中医(TCM)与西医实践相结合的多学科研究,重点强调了用于癌症预防的营养保健品的开发。本研究运用先进的分析化学和食品化学技术,调查了如何优化中药成分以用于营养保健品开发。聚焦于与胃癌相关通路的分子相互作用,特别是核因子κB(NF-κB)、磷脂酰肌醇-3激酶/蛋白激酶B(PI3K/Akt)和Wnt/β-连环蛋白(Wnt/β-catenin)通路,我们研究了中药复方、提取物和分离化合物的作用效果。这些药物可调节细胞凋亡和细胞增殖,凸显了它们在预防策略中的潜力。营养保健品研究与药食同源研究的融合,突出了在预防性健康框架中整合源自中药的化合物的重大转变。这种方法不仅旨在提高疗效和减少副作用,还倡导使用个性化医疗的预防模式,以推进积极的健康维护和疾病预防。中医与西医实践的结合为未来胃癌预防的研究和实际应用提供了有前景的途径。